Karnataka Institute of Medical Sciences, Hubballi (KIMS, Hubli) is a medical school in Hubballi, India and is affiliated to the Rajiv Gandhi University of Health Sciences, Bangalore, Karnataka. It is one of the oldest government tertiary healthcare centers, and the largest multi-specialty hospital in North Karnataka, recognized by the Medical Council of India. In June 1997, the then Karnataka Medical College was accorded autonomous status and became the Karnataka Institute of Medical Sciences, Hubballi.
This study aims to conduct a comprehensive bibliometric analysis to evaluate the scope and progression of Artificial Intelligence (AI) and Machine Learning (ML) applications in Chronic Rhinosinusitis (CRS) within the field of otorhinolaryngology. Specifically, the objective is to analyse publication trends, collaboration networks, and thematic focus areas in the relevant literature, providing insights into the current state and future directions of AI and ML in managing CRS. A comprehensive literature search was conducted in Scopus and PubMed databases for studies published between 1987 and 2024, focusing on AI and ML in CRS. The bibliometrix package in R was utilized for data analysis, including performance assessment, science mapping, and network analysis to identify key contributors, collaboration patterns, and emerging themes within the research landscape. The analysis of 102 documents shows a consistent annual publication growth of 5.78
Rubinstein–Taybi syndrome (RTS) is a rare genetic disorder characterised by distinctive craniofacial features, broad thumbs and toes, microcephaly and neurodevelopmental delays. We report a case of a late preterm neonate presenting with respiratory distress and multiple dysmorphic features, including broad angulated thumbs and great toes, microcephaly, low-set ears and micrognathia. Neuroimaging showed mild thinning of the corpus callosum, and a small patent foramen ovale was noted on echocardiography. Despite normal genetic testing, a clinical diagnosis of RTS was made based on characteristic phenotypic features. Early supportive care with Kangaroo Mother Care, gradual feeding transitions and multidisciplinary follow-up were initiated. This case underscores the importance of clinical recognition in diagnosing syndromic disorders, particularly when genetic confirmation is inconclusive.
Background: Neonatal hypernatremic dehydration is a preventable but potentially severe condition most commonly caused by inadequate breast milk intake in the early neonatal period. We describe the clinical profile, maternal and perinatal risk factors, and short‑term outcomes among breastfed neonates admitted with neonatal hypernatremic dehydration to a tertiary neonatal unit in southern India. Methods: We performed a retrospective observational review (July 2017–June 2022) of neonates ≥35 weeks gestation admitted with serum sodium >145 mmol/L or documented percentage weight loss ≥10% at a tertiary NICU. Demographic, delivery, feeding, clinical and laboratory data were extracted. Continuous data are presented as mean (SD) and categorical data as counts (%). Pearson correlation assessed the relationship between serum sodium and percentage weight loss; p < 0.05 was considered significant. Results: Among 7,552 live births, 105 neonates met inclusion criteria (hospital-based prevalence 1.4%). Mean age at presentation was 4.1 (2.6) days. Mean serum sodium was 153.8 (5.0) mmol/L and mean weight loss 16.3% of birth weight. Seventy‑four percent of mothers were primiparous and 75.2% of deliveries were by cesarean section. Common presenting features were jaundice (82.9%), lethargy (47.6%) and poor feeding (41.9%). Serum sodium correlated positively with percentage weight loss (r = 0.25, p = 0.01). Complications occurred in 22 (21%) neonates as acute kidney injury (18%) and cerebral venous thrombosis (3%) and seizures predominated with sodium ≥160 mmol/L. There were no deaths. Conclusion: Neonatal hypernatremic dehydration among breastfed neonates is an important cause of morbidity that is largely preventable. Routine early postnatal weight monitoring, prompt lactation support particularly for primiparous mothers and following cesarean delivery with early evaluation of neonates with significant weight loss or jaundice may reduce progression to severe hypernatremia and its complications.
Introduction Heart failure (HF) remains a major global health challenge, particularly in low-resource settings where access to comprehensive cardiac rehabilitation (CR) is limited. Yoga, a culturally contextualised mind-body intervention, holds promise as an adjunctive therapy in CR. The Yoga-EndOmics study aims to evaluate the effects of Yoga-based cardiac rehabilitation (Yoga-CaRe) on gene expression, endothelial function, vascular biomarkers and clinical outcomes in systolic HF, providing mechanistic insights into its potential integration into conventional cardiac rehabilitation.Methods and analysis This is a prospective, randomised, open-label, blinded-endpoint (PROBE) mechanistic trial enrolling 78 patients with HF with reduced ejection fraction (HFrEF). Participants will be randomised in a 1:1 ratio to receive either a structured Yoga-CaRe intervention or enhanced standard care for 3 months. The Yoga-CaRe group will attend 20 supervised sessions with guided home practice involving tailored asanas, pranayama and meditation. Primary outcomes are changes in endothelial-dependent flow-mediated dilation (FMD) and functional exercise capacity at 3 months. Secondary outcomes include changes in arterial compliance and stiffness, circulating biomarkers of endothelial dysfunction, oxidative stress and inflammation, and immediate changes in global gene expression profiles in peripheral blood mononuclear cells following the Yoga-CaRe intervention. Data will be analysed using analysis of covariance (ANCOVA) for between-group comparisons and significant analysis of microarray (SAM) for global gene expression profiles.Ethics and dissemination The study has received ethical clearance from the Institutional Ethics Committee of the SDM College of Medical Sciences and Hospital, India (SDMIEC/2025/1072) and is registered with the Clinical Trials Registry of India. Findings will be disseminated through peer-reviewed journals, scientific conferences and stakeholder engagement platforms to inform future integrative strategies in HF management.Trial registration number CTRI/2023/12/060758